Marcus Anthony Urey, MD, University of California, San Diego, CA, comments on the the multidisciplinary management of hereditary transthyretin-mediated (hATTR) amyloidosis, explaining that using a team comprising nephrologists, hematologists, cardiologists, and neurologists will help patients get comprehensive care and experience an improvement in the overall burden of their disease. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.